Exelixis is still an early-stage drug company--though it is one of the best--and Renovis, his last effort, was best known for a very innovative attempt at a stroke drug that did not make it.

FORBES: Magazine Article

Exelixis (nasdaq: EXEL - news - people ) is still an early-stage drug company--though it is one of the best--and Renovis (nasdaq: RNVS - news - people ), his last effort, was best known for a very innovative attempt at a stroke drug that did not make it.

FORBES: Inside Out At Pfizer

McAlister's conversion attempt was wide and France then pulled off a master stroke by bringing on Frederic Michalak to replace Beauxis.

CNN: France shock favorites New Zealand